Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-U.S. to send 4 mln doses of AstraZeneca vaccine to Mexico, Canada in loan deal -official

Thu, 18th Mar 2021 16:59

(Adds Psaki comment)

By Jeff Mason

WASHINGTON, March 18 (Reuters) - The United States plans to
send roughly 4 million doses of AstraZeneca's COVID-19 vaccine
that it is not using to Mexico and Canada in loan deals with the
two countries, an administration official told Reuters on
Thursday.

Mexico will receive 2.5 million doses of the vaccine and
Canada is to receive 1.5 million doses, the official said.

"We're lending a portion of our releasable doses of
AstraZeneca vaccine," the official said on condition of
anonymity. "We only put the virus behind us if we're helping our
global partners."

White House spokeswoman Jen Psaki confirmed the plan, first
reported by Reuters, to send doses to Mexico and Canada. "It is
not fully finalized yet but it is our aim," she told a daily
briefing.

The Biden administration has come under pressure from allies
worldwide to share vaccines, particularly from AstraZeneca,
which is authorized for use in other countries but not yet in
the United States.

AstraZeneca has millions of doses made in a U.S.
facility, and has said that it would have 30 million shots ready
at the beginning of April. The company's shares rose slightly on
the news.

The deal to share the vaccine, which is still being
finalized, does not affect President Joe Biden's plans to have
vaccine available for all adults in the United States by the end
of May, the official said. It does not reduce the supply of
available vaccine in the United States.

The deal is likely to be announced publicly in the coming
days.

Two officials said the vaccine would be delivered in "short
order" once the deal was completed, but they declined to give a
more specific timetable.

The "releasable" vaccines are ready to be used once they
arrive. Under the deal, the United States will share doses with
Mexico and Canada now with the understanding that they will pay
the United States back with doses in return. The official said
that would take place later this year.

The United States had no plans to share the vaccine with
other countries at this time, he said.

"They are our neighbors, they are our partners," the
official said about Mexico and Canada. Mexican President Andres
Manuel Lopez Obrador had requested the vaccine previously. The
official said the countries were in touch about the vaccine
loan. "We've been working through the diplomatic channels," he
said.

Reports of blood disorders have prompted more than a dozen
nations to suspend use of AstraZeneca's vaccine but on Thursday
the EU's drug watchdog said that after an investigation it is
still convinced the benefits of that vaccine outweigh the risks.

Biden has said if the United States has a surplus of
vaccine, it will share it with the rest of the world. The White
House has focused on vaccinating people in the United States,
which has seen more than 530,000 people die from virus.

The country was getting prepared to roll out the AstraZeneca
vaccine domestically if it gets authorization from the U.S. Food
and Drug Administration, the official said.

The official noted that the United States has pledged $4
billion to the COVAX vaccine facility that aims to deliver
coronavirus vaccines to poor countries.

The United States does not need the AstraZeneca shots to
meet its target of having enough doses for all U.S. adults by
the end of May.

The three authorized vaccine makers – Pfizer Inc/BioNTech
SE, Moderna Inc, and Johnson & Johnson – have promised to
deliver nearly 500 million doses to the United States by then.
(Reporting by Jeff Mason; additional reporting by Trevor
Hunnicutt and Caroline Humer; Editing by Heather Timmons and
Alistair Bell)

More News
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.